1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 General Treatment
1.2.3 Traditional Chinese Medicine
1.2.4 Gene Therapy
1.2.5 The Surgical Treatment
1.2.6 Other
1.3 Market by Application
1.3.1 Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Retinitis Pigmentosa (Retinitis) Market Perspective (2017-2028)
2.2 Retinitis Pigmentosa (Retinitis) Growth Trends by Region
2.2.1 Retinitis Pigmentosa (Retinitis) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Retinitis Pigmentosa (Retinitis) Historic Market Size by Region (2017-2022)
2.2.3 Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Region (2023-2028)
2.3 Retinitis Pigmentosa (Retinitis) Market Dynamics
2.3.1 Retinitis Pigmentosa (Retinitis) Industry Trends
2.3.2 Retinitis Pigmentosa (Retinitis) Market Drivers
2.3.3 Retinitis Pigmentosa (Retinitis) Market Challenges
2.3.4 Retinitis Pigmentosa (Retinitis) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinitis Pigmentosa (Retinitis) Players by Revenue
3.1.1 Global Top Retinitis Pigmentosa (Retinitis) Players by Revenue (2017-2022)
3.1.2 Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Players (2017-2022)
3.2 Global Retinitis Pigmentosa (Retinitis) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Retinitis Pigmentosa (Retinitis) Revenue
3.4 Global Retinitis Pigmentosa (Retinitis) Market Concentration Ratio
3.4.1 Global Retinitis Pigmentosa (Retinitis) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinitis Pigmentosa (Retinitis) Revenue in 2021
3.5 Retinitis Pigmentosa (Retinitis) Key Players Head office and Area Served
3.6 Key Players Retinitis Pigmentosa (Retinitis) Product Solution and Service
3.7 Date of Enter into Retinitis Pigmentosa (Retinitis) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinitis Pigmentosa (Retinitis) Breakdown Data by Type
4.1 Global Retinitis Pigmentosa (Retinitis) Historic Market Size by Type (2017-2022)
4.2 Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Type (2023-2028)
5 Retinitis Pigmentosa (Retinitis) Breakdown Data by Application
5.1 Global Retinitis Pigmentosa (Retinitis) Historic Market Size by Application (2017-2022)
5.2 Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Retinitis Pigmentosa (Retinitis) Market Size (2017-2028)
6.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Type
6.2.1 North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2022)
6.2.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2023-2028)
6.2.3 North America Retinitis Pigmentosa (Retinitis) Market Share by Type (2017-2028)
6.3 North America Retinitis Pigmentosa (Retinitis) Market Size by Application
6.3.1 North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2022)
6.3.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2023-2028)
6.3.3 North America Retinitis Pigmentosa (Retinitis) Market Share by Application (2017-2028)
6.4 North America Retinitis Pigmentosa (Retinitis) Market Size by Country
6.4.1 North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022)
6.4.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Retinitis Pigmentosa (Retinitis) Market Size (2017-2028)
7.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Type
7.2.1 Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2022)
7.2.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2023-2028)
7.2.3 Europe Retinitis Pigmentosa (Retinitis) Market Share by Type (2017-2028)
7.3 Europe Retinitis Pigmentosa (Retinitis) Market Size by Application
7.3.1 Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2022)
7.3.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2023-2028)
7.3.3 Europe Retinitis Pigmentosa (Retinitis) Market Share by Application (2017-2028)
7.4 Europe Retinitis Pigmentosa (Retinitis) Market Size by Country
7.4.1 Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022)
7.4.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size (2017-2028)
8.2 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Type
8.2.1 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Share by Type (2017-2028)
8.3 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Application
8.3.1 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Share by Application (2017-2028)
8.4 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Region
8.4.1 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Retinitis Pigmentosa (Retinitis) Market Size (2017-2028)
9.2 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type
9.2.1 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2022)
9.2.2 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2023-2028)
9.2.3 Latin America Retinitis Pigmentosa (Retinitis) Market Share by Type (2017-2028)
9.3 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application
9.3.1 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2022)
9.3.2 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2023-2028)
9.3.3 Latin America Retinitis Pigmentosa (Retinitis) Market Share by Application (2017-2028)
9.4 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country
9.4.1 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022)
9.4.2 Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size (2017-2028)
10.2 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Type
10.2.1 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Share by Type (2017-2028)
10.3 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Application
10.3.1 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Share by Application (2017-2028)
10.4 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Country
10.4.1 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Retinitis Pigmentosa (Retinitis) Introduction
11.1.4 Sanofi Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Retinitis Pigmentosa (Retinitis) Introduction
11.2.4 Amgen Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.2.5 Amgen Recent Developments
11.3 Amarantus Bioscience Holdings
11.3.1 Amarantus Bioscience Holdings Company Details
11.3.2 Amarantus Bioscience Holdings Business Overview
11.3.3 Amarantus Bioscience Holdings Retinitis Pigmentosa (Retinitis) Introduction
11.3.4 Amarantus Bioscience Holdings Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.3.5 Amarantus Bioscience Holdings Recent Developments
11.4 Acucela
11.4.1 Acucela Company Details
11.4.2 Acucela Business Overview
11.4.3 Acucela Retinitis Pigmentosa (Retinitis) Introduction
11.4.4 Acucela Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.4.5 Acucela Recent Developments
11.5 Applied Genetic Technologies Corp
11.5.1 Applied Genetic Technologies Corp Company Details
11.5.2 Applied Genetic Technologies Corp Business Overview
11.5.3 Applied Genetic Technologies Corp Retinitis Pigmentosa (Retinitis) Introduction
11.5.4 Applied Genetic Technologies Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.5.5 Applied Genetic Technologies Corp Recent Developments
11.6 Asklepios BioPharmaceutical
11.6.1 Asklepios BioPharmaceutical Company Details
11.6.2 Asklepios BioPharmaceutical Business Overview
11.6.3 Asklepios BioPharmaceutical Retinitis Pigmentosa (Retinitis) Introduction
11.6.4 Asklepios BioPharmaceutical Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.6.5 Asklepios BioPharmaceutical Recent Developments
11.7 Astellas Pharma
11.7.1 Astellas Pharma Company Details
11.7.2 Astellas Pharma Business Overview
11.7.3 Astellas Pharma Retinitis Pigmentosa (Retinitis) Introduction
11.7.4 Astellas Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.7.5 Astellas Pharma Recent Developments
11.8 Caladrius Biosciences
11.8.1 Caladrius Biosciences Company Details
11.8.2 Caladrius Biosciences Business Overview
11.8.3 Caladrius Biosciences Retinitis Pigmentosa (Retinitis) Introduction
11.8.4 Caladrius Biosciences Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.8.5 Caladrius Biosciences Recent Developments
11.9 Dompe Farmaceutici SpA
11.9.1 Dompe Farmaceutici SpA Company Details
11.9.2 Dompe Farmaceutici SpA Business Overview
11.9.3 Dompe Farmaceutici SpA Retinitis Pigmentosa (Retinitis) Introduction
11.9.4 Dompe Farmaceutici SpA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.9.5 Dompe Farmaceutici SpA Recent Developments
11.10 Dormant Projects
11.10.1 Dormant Projects Company Details
11.10.2 Dormant Projects Business Overview
11.10.3 Dormant Projects Retinitis Pigmentosa (Retinitis) Introduction
11.10.4 Dormant Projects Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.10.5 Dormant Projects Recent Developments
11.11 GenSight Biologics SA
11.11.1 GenSight Biologics SA Company Details
11.11.2 GenSight Biologics SA Business Overview
11.11.3 GenSight Biologics SA Retinitis Pigmentosa (Retinitis) Introduction
11.11.4 GenSight Biologics SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.11.5 GenSight Biologics SA Recent Developments
11.12 Grupo Ferrer Internacional SA
11.12.1 Grupo Ferrer Internacional SA Company Details
11.12.2 Grupo Ferrer Internacional SA Business Overview
11.12.3 Grupo Ferrer Internacional SA Retinitis Pigmentosa (Retinitis) Introduction
11.12.4 Grupo Ferrer Internacional SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.12.5 Grupo Ferrer Internacional SA Recent Developments
11.13 ID Pharma
11.13.1 ID Pharma Company Details
11.13.2 ID Pharma Business Overview
11.13.3 ID Pharma Retinitis Pigmentosa (Retinitis) Introduction
11.13.4 ID Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.13.5 ID Pharma Recent Developments
11.14 InFlectis BioScience
11.14.1 InFlectis BioScience Company Details
11.14.2 InFlectis BioScience Business Overview
11.14.3 InFlectis BioScience Retinitis Pigmentosa (Retinitis) Introduction
11.14.4 InFlectis BioScience Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.14.5 InFlectis BioScience Recent Developments
11.15 Ionis Pharmaceuticals
11.15.1 Ionis Pharmaceuticals Company Details
11.15.2 Ionis Pharmaceuticals Business Overview
11.15.3 Ionis Pharmaceuticals Retinitis Pigmentosa (Retinitis) Introduction
11.15.4 Ionis Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.15.5 Ionis Pharmaceuticals Recent Developments
11.16 Mimetogen Pharmaceuticals
11.16.1 Mimetogen Pharmaceuticals Company Details
11.16.2 Mimetogen Pharmaceuticals Business Overview
11.16.3 Mimetogen Pharmaceuticals Retinitis Pigmentosa (Retinitis) Introduction
11.16.4 Mimetogen Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.16.5 Mimetogen Pharmaceuticals Recent Developments
11.17 M's Science Corp
11.17.1 M's Science Corp Company Details
11.17.2 M's Science Corp Business Overview
11.17.3 M's Science Corp Retinitis Pigmentosa (Retinitis) Introduction
11.17.4 M's Science Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.17.5 M's Science Corp Recent Developments
11.18 Nanovector srl
11.18.1 Nanovector srl Company Details
11.18.2 Nanovector srl Business Overview
11.18.3 Nanovector srl Retinitis Pigmentosa (Retinitis) Introduction
11.18.4 Nanovector srl Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.18.5 Nanovector srl Recent Developments
11.19 Novartis AG
11.19.1 Novartis AG Company Details
11.19.2 Novartis AG Business Overview
11.19.3 Novartis AG Retinitis Pigmentosa (Retinitis) Introduction
11.19.4 Novartis AG Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.19.5 Novartis AG Recent Developments
11.20 Novelion Therapeutics
11.20.1 Novelion Therapeutics Company Details
11.20.2 Novelion Therapeutics Business Overview
11.20.3 Novelion Therapeutics Retinitis Pigmentosa (Retinitis) Introduction
11.20.4 Novelion Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.20.5 Novelion Therapeutics Recent Developments
11.21 ProQR Therapeutics
11.21.1 ProQR Therapeutics Company Details
11.21.2 ProQR Therapeutics Business Overview
11.21.3 ProQR Therapeutics Retinitis Pigmentosa (Retinitis) Introduction
11.21.4 ProQR Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.21.5 ProQR Therapeutics Recent Developments
11.22 ReNeuron Group Plc
11.22.1 ReNeuron Group Plc Company Details
11.22.2 ReNeuron Group Plc Business Overview
11.22.3 ReNeuron Group Plc Retinitis Pigmentosa (Retinitis) Introduction
11.22.4 ReNeuron Group Plc Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.22.5 ReNeuron Group Plc Recent Developments
11.23 SanBio
11.23.1 SanBio Company Details
11.23.2 SanBio Business Overview
11.23.3 SanBio Retinitis Pigmentosa (Retinitis) Introduction
11.23.4 SanBio Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.23.5 SanBio Recent Developments
11.24 Shire (Takeda Pharmaceutical)
11.24.1 Shire (Takeda Pharmaceutical) Company Details
11.24.2 Shire (Takeda Pharmaceutical) Business Overview
11.24.3 Shire (Takeda Pharmaceutical) Retinitis Pigmentosa (Retinitis) Introduction
11.24.4 Shire (Takeda Pharmaceutical) Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.24.5 Shire (Takeda Pharmaceutical) Recent Developments
11.25 Spark Therapeutics
11.25.1 Spark Therapeutics Company Details
11.25.2 Spark Therapeutics Business Overview
11.25.3 Spark Therapeutics Retinitis Pigmentosa (Retinitis) Introduction
11.25.4 Spark Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.25.5 Spark Therapeutics Recent Developments
11.26 Sun Pharma Advanced Research Company
11.26.1 Sun Pharma Advanced Research Company Company Details
11.26.2 Sun Pharma Advanced Research Company Business Overview
11.26.3 Sun Pharma Advanced Research Company Retinitis Pigmentosa (Retinitis) Introduction
11.26.4 Sun Pharma Advanced Research Company Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
11.26.5 Sun Pharma Advanced Research Company Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of General Treatment
Table 3. Key Players of Traditional Chinese Medicine
Table 4. Key Players of Gene Therapy
Table 5. Key Players of The Surgical Treatment
Table 6. Key Players of Other
Table 7. Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Retinitis Pigmentosa (Retinitis) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Retinitis Pigmentosa (Retinitis) Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Retinitis Pigmentosa (Retinitis) Market Share by Region (2017-2022)
Table 11. Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Retinitis Pigmentosa (Retinitis) Market Share by Region (2023-2028)
Table 13. Retinitis Pigmentosa (Retinitis) Market Trends
Table 14. Retinitis Pigmentosa (Retinitis) Market Drivers
Table 15. Retinitis Pigmentosa (Retinitis) Market Challenges
Table 16. Retinitis Pigmentosa (Retinitis) Market Restraints
Table 17. Global Retinitis Pigmentosa (Retinitis) Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Retinitis Pigmentosa (Retinitis) Revenue Share by Players (2017-2022)
Table 19. Global Top Retinitis Pigmentosa (Retinitis) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinitis Pigmentosa (Retinitis) as of 2021)
Table 20. Ranking of Global Top Retinitis Pigmentosa (Retinitis) Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Retinitis Pigmentosa (Retinitis) Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Retinitis Pigmentosa (Retinitis) Product Solution and Service
Table 24. Date of Enter into Retinitis Pigmentosa (Retinitis) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Type (2017-2022)
Table 28. Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Type (2023-2028)
Table 30. Global Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Retinitis Pigmentosa (Retinitis) Revenue Share by Application (2017-2022)
Table 32. Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Retinitis Pigmentosa (Retinitis) Revenue Share by Application (2023-2028)
Table 34. North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Retinitis Pigmentosa (Retinitis) Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Retinitis Pigmentosa (Retinitis) Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Retinitis Pigmentosa (Retinitis) Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Retinitis Pigmentosa (Retinitis) Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Retinitis Pigmentosa (Retinitis) Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Retinitis Pigmentosa (Retinitis) Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Retinitis Pigmentosa (Retinitis) Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Retinitis Pigmentosa (Retinitis) Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Retinitis Pigmentosa (Retinitis) Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Retinitis Pigmentosa (Retinitis) Market Size by Country (2023-2028) & (US$ Million)
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi Retinitis Pigmentosa (Retinitis) Product
Table 67. Sanofi Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 68. Sanofi Recent Developments
Table 69. Amgen Company Details
Table 70. Amgen Business Overview
Table 71. Amgen Retinitis Pigmentosa (Retinitis) Product
Table 72. Amgen Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 73. Amgen Recent Developments
Table 74. Amarantus Bioscience Holdings Company Details
Table 75. Amarantus Bioscience Holdings Business Overview
Table 76. Amarantus Bioscience Holdings Retinitis Pigmentosa (Retinitis) Product
Table 77. Amarantus Bioscience Holdings Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 78. Amarantus Bioscience Holdings Recent Developments
Table 79. Acucela Company Details
Table 80. Acucela Business Overview
Table 81. Acucela Retinitis Pigmentosa (Retinitis) Product
Table 82. Acucela Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 83. Acucela Recent Developments
Table 84. Applied Genetic Technologies Corp Company Details
Table 85. Applied Genetic Technologies Corp Business Overview
Table 86. Applied Genetic Technologies Corp Retinitis Pigmentosa (Retinitis) Product
Table 87. Applied Genetic Technologies Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 88. Applied Genetic Technologies Corp Recent Developments
Table 89. Asklepios BioPharmaceutical Company Details
Table 90. Asklepios BioPharmaceutical Business Overview
Table 91. Asklepios BioPharmaceutical Retinitis Pigmentosa (Retinitis) Product
Table 92. Asklepios BioPharmaceutical Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 93. Asklepios BioPharmaceutical Recent Developments
Table 94. Astellas Pharma Company Details
Table 95. Astellas Pharma Business Overview
Table 96. Astellas Pharma Retinitis Pigmentosa (Retinitis) Product
Table 97. Astellas Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 98. Astellas Pharma Recent Developments
Table 99. Caladrius Biosciences Company Details
Table 100. Caladrius Biosciences Business Overview
Table 101. Caladrius Biosciences Retinitis Pigmentosa (Retinitis) Product
Table 102. Caladrius Biosciences Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 103. Caladrius Biosciences Recent Developments
Table 104. Dompe Farmaceutici SpA Company Details
Table 105. Dompe Farmaceutici SpA Business Overview
Table 106. Dompe Farmaceutici SpA Retinitis Pigmentosa (Retinitis) Product
Table 107. Dompe Farmaceutici SpA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 108. Dompe Farmaceutici SpA Recent Developments
Table 109. Dormant Projects Company Details
Table 110. Dormant Projects Business Overview
Table 111. Dormant Projects Retinitis Pigmentosa (Retinitis) Product
Table 112. Dormant Projects Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 113. Dormant Projects Recent Developments
Table 114. GenSight Biologics SA Company Details
Table 115. GenSight Biologics SA Business Overview
Table 116. GenSight Biologics SA Retinitis Pigmentosa (Retinitis) Product
Table 117. GenSight Biologics SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 118. GenSight Biologics SA Recent Developments
Table 119. Grupo Ferrer Internacional SA Company Details
Table 120. Grupo Ferrer Internacional SA Business Overview
Table 121. Grupo Ferrer Internacional SA Retinitis Pigmentosa (Retinitis) Product
Table 122. Grupo Ferrer Internacional SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 123. Grupo Ferrer Internacional SA Recent Developments
Table 124. ID Pharma Company Details
Table 125. ID Pharma Business Overview
Table 126. ID Pharma Retinitis Pigmentosa (Retinitis) Product
Table 127. ID Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 128. ID Pharma Recent Developments
Table 129. InFlectis BioScience Company Details
Table 130. InFlectis BioScience Business Overview
Table 131. InFlectis BioScience Retinitis Pigmentosa (Retinitis) Product
Table 132. InFlectis BioScience Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 133. InFlectis BioScience Recent Developments
Table 134. Ionis Pharmaceuticals Company Details
Table 135. Ionis Pharmaceuticals Business Overview
Table 136. Ionis Pharmaceuticals Retinitis Pigmentosa (Retinitis) Product
Table 137. Ionis Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 138. Ionis Pharmaceuticals Recent Developments
Table 139. Mimetogen Pharmaceuticals Company Details
Table 140. Mimetogen Pharmaceuticals Business Overview
Table 141. Mimetogen Pharmaceuticals Retinitis Pigmentosa (Retinitis) Product
Table 142. Mimetogen Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 143. Mimetogen Pharmaceuticals Recent Developments
Table 144. M's Science Corp Company Details
Table 145. M's Science Corp Business Overview
Table 146. M's Science Corp Retinitis Pigmentosa (Retinitis) Product
Table 147. M's Science Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 148. M's Science Corp Recent Developments
Table 149. Nanovector srl Company Details
Table 150. Nanovector srl Business Overview
Table 151. Nanovector srl Retinitis Pigmentosa (Retinitis) Product
Table 152. Nanovector srl Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 153. Nanovector srl Recent Developments
Table 154. Novartis AG Company Details
Table 155. Novartis AG Business Overview
Table 156. Novartis AG Retinitis Pigmentosa (Retinitis) Product
Table 157. Novartis AG Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 158. Novartis AG Recent Developments
Table 159. Novelion Therapeutics Company Details
Table 160. Novelion Therapeutics Business Overview
Table 161. Novelion Therapeutics Retinitis Pigmentosa (Retinitis) Product
Table 162. Novelion Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 163. Novelion Therapeutics Recent Developments
Table 164. ProQR Therapeutics Company Details
Table 165. ProQR Therapeutics Business Overview
Table 166. ProQR Therapeutics Retinitis Pigmentosa (Retinitis) Product
Table 167. ProQR Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 168. ProQR Therapeutics Recent Developments
Table 169. ReNeuron Group Plc Company Details
Table 170. ReNeuron Group Plc Business Overview
Table 171. ReNeuron Group Plc Retinitis Pigmentosa (Retinitis) Product
Table 172. ReNeuron Group Plc Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 173. ReNeuron Group Plc Recent Developments
Table 174. SanBio Company Details
Table 175. SanBio Business Overview
Table 176. SanBio Retinitis Pigmentosa (Retinitis) Product
Table 177. SanBio Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 178. SanBio Recent Developments
Table 179. Shire (Takeda Pharmaceutical) Company Details
Table 180. Shire (Takeda Pharmaceutical) Business Overview
Table 181. Shire (Takeda Pharmaceutical) Retinitis Pigmentosa (Retinitis) Product
Table 182. Shire (Takeda Pharmaceutical) Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 183. Shire (Takeda Pharmaceutical) Recent Developments
Table 184. Spark Therapeutics Company Details
Table 185. Spark Therapeutics Business Overview
Table 186. Spark Therapeutics Retinitis Pigmentosa (Retinitis) Product
Table 187. Spark Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 188. Spark Therapeutics Recent Developments
Table 189. Sun Pharma Advanced Research Company Company Details
Table 190. Sun Pharma Advanced Research Company Business Overview
Table 191. Sun Pharma Advanced Research Company Retinitis Pigmentosa (Retinitis) Product
Table 192. Sun Pharma Advanced Research Company Revenue in Retinitis Pigmentosa (Retinitis) Business (2017-2022) & (US$ Million)
Table 193. Sun Pharma Advanced Research Company Recent Developments
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinitis Pigmentosa (Retinitis) Market Share by Type: 2021 VS 2028
Figure 2. General Treatment Features
Figure 3. Traditional Chinese Medicine Features
Figure 4. Gene Therapy Features
Figure 5. The Surgical Treatment Features
Figure 6. Other Features
Figure 7. Global Retinitis Pigmentosa (Retinitis) Market Share by Application: 2021 VS 2028
Figure 8. Hospitals Case Studies
Figure 9. Eye Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Retinitis Pigmentosa (Retinitis) Report Years Considered
Figure 12. Global Retinitis Pigmentosa (Retinitis) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Retinitis Pigmentosa (Retinitis) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Retinitis Pigmentosa (Retinitis) Market Share by Region: 2021 VS 2028
Figure 15. Global Retinitis Pigmentosa (Retinitis) Market Share by Players in 2021
Figure 16. Global Top Retinitis Pigmentosa (Retinitis) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinitis Pigmentosa (Retinitis) as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Retinitis Pigmentosa (Retinitis) Revenue in 2021
Figure 18. North America Retinitis Pigmentosa (Retinitis) Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Retinitis Pigmentosa (Retinitis) Market Size Market Share by Type (2017-2028)
Figure 20. North America Retinitis Pigmentosa (Retinitis) Market Size Market Share by Application (2017-2028)
Figure 21. North America Retinitis Pigmentosa (Retinitis) Market Size Share by Country (2017-2028)
Figure 22. United States Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Retinitis Pigmentosa (Retinitis) Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Retinitis Pigmentosa (Retinitis) Market Size Market Share by Type (2017-2028)
Figure 26. Europe Retinitis Pigmentosa (Retinitis) Market Size Market Share by Application (2017-2028)
Figure 27. Europe Retinitis Pigmentosa (Retinitis) Market Size Share by Country (2017-2028)
Figure 28. Germany Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Retinitis Pigmentosa (Retinitis) Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Retinitis Pigmentosa (Retinitis) Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Retinitis Pigmentosa (Retinitis) Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Retinitis Pigmentosa (Retinitis) Market Size Share by Region (2017-2028)
Figure 38. China Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Retinitis Pigmentosa (Retinitis) Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Retinitis Pigmentosa (Retinitis) Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Retinitis Pigmentosa (Retinitis) Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Retinitis Pigmentosa (Retinitis) Market Size Share by Country (2017-2028)
Figure 48. Mexico Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Retinitis Pigmentosa (Retinitis) Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Retinitis Pigmentosa (Retinitis) Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Retinitis Pigmentosa (Retinitis) Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Retinitis Pigmentosa (Retinitis) Market Size Share by Country (2017-2028)
Figure 54. Turkey Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Sanofi Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 58. Amgen Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 59. Amarantus Bioscience Holdings Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 60. Acucela Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 61. Applied Genetic Technologies Corp Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 62. Asklepios BioPharmaceutical Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 63. Astellas Pharma Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 64. Caladrius Biosciences Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 65. Dompe Farmaceutici SpA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 66. Dormant Projects Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 67. GenSight Biologics SA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 68. Grupo Ferrer Internacional SA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 69. ID Pharma Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 70. InFlectis BioScience Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 71. Ionis Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 72. Mimetogen Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 73. M's Science Corp Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 74. Nanovector srl Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 75. Novartis AG Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 76. Novelion Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 77. ProQR Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 78. ReNeuron Group Plc Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 79. SanBio Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 80. Shire (Takeda Pharmaceutical) Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 81. Spark Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 82. Sun Pharma Advanced Research Company Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2017-2022)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
